Connection

Jacqueline Kraveka to Immunotherapy

Back to Details
This is a "connection" page, showing publications Jacqueline Kraveka has written about Immunotherapy.
Jacqueline Kraveka
Connection Strength
0.176
Immunotherapy
  1. A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. Cancer Rep (Hoboken). 2022 Nov; 5(11):e1616.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.